We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+15.81%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$603M
AUM Growth
-$8.68M
Cap. Flow
-$46.2M
Cap. Flow %
-7.66%
Top 10 Hldgs %
7.77%
Holding
1,678
New
527
Increased
200
Reduced
321
Closed
629

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$7.12M
2
GOTU icon
Gaotu Techedu
GOTU
+$6.67M
3
PARA
Paramount Global Class B
PARA
+$5.77M
4
VIPS icon
Vipshop
VIPS
+$5.57M
5
TME icon
Tencent Music
TME
+$5.35M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.29%
2 Healthcare 13.21%
3 Industrials 11.54%
4 Technology 11.13%
5 Financials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRST
376
Trustco Bank Corp NY
TRST
$938M
$480K 0.08%
13,031
-5,815
-31% -$205K
TEN
377
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$480K 0.08%
+44,763
New +$489K
WHR icon
378
Whirlpool
WHR
$2.82B
$479K 0.08%
2,176
+868
+66% +$172K
LAB icon
379
Standard BioTools
LAB
$314M
$478K 0.08%
105,852
+63,908
+152% +$351K
MLI icon
380
Mueller Industries
MLI
$15.2B
$478K 0.08%
+46,284
New +$455K
IT icon
381
Gartner
IT
$11.7B
$476K 0.08%
+2,608
New +$453K
AM icon
382
Antero Midstream
AM
$10.1B
$475K 0.08%
+52,628
New +$454K
ATRC icon
383
AtriCure
ATRC
$2.11B
$475K 0.08%
+7,254
New +$447K
CDTX
384
DELISTED
Cidara Therapeutics
CDTX
$475K 0.08%
8,937
-39
-0.4% -$1.93K
CLX icon
385
Clorox
CLX
$12.7B
$475K 0.08%
2,461
-3,457
-58% -$665K
GILD icon
386
Gilead Sciences
GILD
$165B
$475K 0.08%
+7,342
New +$473K
COO icon
387
Cooper Companies
COO
$14.5B
$473K 0.08%
+4,924
New +$467K
CTSH icon
388
Cognizant
CTSH
$26B
$473K 0.08%
+6,059
New +$468K
GPRE icon
389
Green Plains
GPRE
$1.03B
$472K 0.08%
17,443
-11,507
-40% -$263K
MELI icon
390
Mercado Libre
MELI
$92.3B
$471K 0.08%
320
-377
-54% -$640K
GSBC icon
391
Great Southern Bancorp
GSBC
$878M
$469K 0.08%
+8,274
New +$442K
CRM icon
392
Salesforce
CRM
$158B
$465K 0.08%
+2,193
New +$488K
BBSI icon
393
Barrett Business Services
BBSI
$804M
$464K 0.08%
26,980
+14,656
+119% +$256K
EVFM
394
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$464K 0.08%
17,686
+666
+4% +$30.3K
CYBE
395
DELISTED
Cyberoptics Corp
CYBE
$463K 0.08%
17,832
-3,268
-15% -$84.9K
CMRX
396
DELISTED
Chimerix, Inc.
CMRX
$462K 0.08%
47,921
-78,986
-62% -$725K
TT icon
397
Trane Technologies
TT
$106B
$460K 0.08%
2,779
-421
-13% -$65.2K
TWI icon
398
Titan International
TWI
$475M
$460K 0.08%
49,610
-96,353
-66% -$756K
WPC icon
399
W.P. Carey
WPC
$16.4B
$460K 0.08%
+6,642
New +$445K
CNOB icon
400
Center Bancorp
CNOB
$1.78B
$459K 0.08%
+18,118
New +$427K

Similar funds

GSA Capital Partners's Q1 2021 Portfolio in Review

As of Q1 2021, GSA Capital Partners held 1,678 positions worth $603M, down 1.4% from $611M the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

GSA Capital Partners withdrew a net $46.2M in Q1 2021, closing 629 positions and reducing 321 holdings. Its most notable exit was Just Eat Takeaway.com N.V. American Depositary Shares, an estimated $3.36M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, GSA Capital Partners opened a new position in Baidu worth $5.94M.

  • GSA Capital Partners's largest Q1 2021 buy was Baidu: 27,291 shares worth $5.94M.
  • GSA Capital Partners added most to Tencent Music in Q1 2021, an estimated $5.35M increase.
  • GSA Capital Partners's biggest Q1 2021 reduction was Medifast, cutting an estimated $2.5M.
  • GSA Capital Partners fully exited Just Eat Takeaway.com N.V. American Depositary Shares in Q1 2021, selling an estimated $3.36M.
  • GSA Capital Partners's ten largest holdings make up 7.8% of its $603M portfolio in Q1 2021.
  • GSA Capital Partners opened 527 new positions and closed 629 in Q1 2021.
  • GSA Capital Partners's portfolio value fell 1.4% quarter-over-quarter to $603M.

Based on GSA Capital Partners's 13F filing for Q1 2021, filed 10 May 2021.